Amedisys Revenue 2010-2024 | AMED

Amedisys revenue from 2010 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
Amedisys Annual Revenue
(Millions of US $)
2023 $2,236
2022 $2,223
2021 $2,227
2020 $2,106
2019 $1,956
2018 $1,663
2017 $1,511
2016 $1,419
2015 $1,281
2014 $1,205
2013 $1,249
2012 $1,441
2011 $1,418
2010 $1,601
2009 $1,484
Amedisys Quarterly Revenue
(Millions of US $)
2024-03-31 $571
2023-12-31 $571
2023-09-30 $556
2023-06-30 $553
2023-03-31 $556
2022-12-31 $562
2022-09-30 $558
2022-06-30 $558
2022-03-31 $545
2021-12-31 $559
2021-09-30 $553
2021-06-30 $569
2021-03-31 $546
2020-12-31 $557
2020-09-30 $549
2020-06-30 $508
2020-03-31 $492
2019-12-31 $501
2019-09-30 $495
2019-06-30 $493
2019-03-31 $467
2018-12-31 $434
2018-09-30 $417
2018-06-30 $412
2018-03-31 $399
2017-12-31 $398
2017-09-30 $374
2017-06-30 $375
2017-03-31 $365
2016-12-31 $348
2016-09-30 $362
2016-06-30 $361
2016-03-31 $349
2015-12-31 $338
2015-09-30 $326
2015-06-30 $314
2015-03-31 $302
2014-12-31 $301
2014-09-30 $300
2014-06-30 $305
2014-03-31 $299
2013-12-31 $303
2013-09-30 $301
2013-06-30 $316
2013-03-31 $329
2012-12-31 $343
2012-09-30 $364
2012-06-30 $363
2012-03-31 $371
2011-12-31 $320
2011-09-30 $370
2011-06-30 $368
2011-03-31 $359
2010-12-31 $361
2010-09-30 $405
2010-06-30 $422
2010-03-31 $413
2009-12-31 $376
2009-09-30 $388
2009-06-30 $378
2009-03-31 $342
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $2.993B $2.236B
Amedisys Inc. provides home health and hospice services throughout the U.S. to the growing chronic, co-morbid, and aging American population. The company also offers clinically focused programs for chronic conditions and various diseases such as diabetes, coronary artery disease, congestive heart failure, orthopedics, complex wound care, geriatric surgical recovery, balance retraining, behavioral health and stroke recovery, as well as various rehabilitative programs. It provides hospice services to patients using an interdisciplinary care team comprising a physician, nurses, home health aides, social workers, therapists, dieticians, volunteers, counselors, chaplains and bereavement coordinators, when required. The company depends on reimbursement from Medicare (for chronic care) for a significant portion of its revenues on account of the age demographics of its patient base (average age of 81).
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $17.002B 10.28
Quest Diagnostics (DGX) United States $15.353B 15.87
DaVita (DVA) United States $12.299B 15.28
Elanco Animal Health (ELAN) United States $8.994B 23.33
Encompass Health (EHC) United States $8.506B 21.77
Chemed (CHE) United States $8.076B 25.03
Option Care Health (OPCH) United States $4.839B 18.32
RadNet (RDNT) United States $4.232B 88.12
Astrana Health (ASTH) United States $2.272B 30.72
LifeStance Health (LFST) United States $2.018B 0.00
Addus HomeCare (ADUS) United States $1.914B 27.38
U.S Physical Therapy (USPH) United States $1.400B 37.46
Pennant (PNTG) United States $0.662B 34.98
Aveanna Healthcare Holdings (AVAH) United States $0.491B 0.00
Atai Life Sciences (ATAI) Germany $0.223B 0.00
Daxor (DXR) United States $0.042B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.024B 0.00
ATI Physical Therapy (ATIP) United States $0.022B 0.00
Novo Integrated Sciences (NVOS) United States $0.014B 0.00
Psychemedics (PMD) United States $0.013B 0.00
Ontrak (OTRK) United States $0.011B 0.00
IMAC Holdings (BACK) United States $0.003B 0.00